凝血因子VIII在内质网中发生伴侣蛋白依赖和葡萄糖调节的可逆淀粉样蛋白形成
本研究探讨血友病A治疗中凝血因子VIII(FVIII)在内质网内聚集的机制。FVIII合成增加或葡萄糖代谢受抑制时会在内质网腔内形成淀粉样纤维,恢复葡萄糖代谢后淀粉样蛋白可溶解并分泌功能性FVIII。BiP和钙连接蛋白/钙网蛋白两大家族及其共伴侣蛋白促进FVIII可溶性,其中BiP还参与解聚;FVIII A1结构域中短聚集基序(Aggron)是β-折叠聚合的必要充分条件,BiP结合该基序可阻止淀粉样形成。
要点
- FVIII合成增加或抑制葡萄糖代谢时在内质网腔内形成淀粉样纤维。
- 恢复葡萄糖代谢可溶解FVIII淀粉样蛋白并分泌功能性FVIII。
- BiP和钙连接蛋白/钙网蛋白促进FVIII可溶性,BiP还参与解聚。
核心结论
- FVIII在内质网中可形成可逆的淀粉样纤维,该过程受葡萄糖代谢和ER伴侣蛋白调控。
- FVIII A1结构域的Aggron基序足以引发β-折叠聚合,BiP结合该基序可阻止淀粉样形成。
研究设计与样本
- 基础研究,未报告样本量。
- 通过增加FVIII合成或抑制葡萄糖代谢诱导FVIII聚集,观察内质网腔内淀粉样纤维形成及溶解。
主要发现
- FVIII合成增加或抑制葡萄糖代谢时,FVIII在内质网腔内形成淀粉样纤维。
- 恢复葡萄糖代谢后FVIII淀粉样蛋白可溶解,产生功能性分泌FVIII。
- BiP和钙连接蛋白/钙网蛋白两大家族及其共伴侣蛋白促进FVIII在内质网中可溶性,其中BiP还参与解聚。
- FVIII A1结构域中短聚集基序Aggron是β-折叠聚合的必要充分条件,BiP结合该基序阻止淀粉样形成。
临床怎么用
- 为血友病A基因治疗临床试验中改善FVIII分泌提供机制线索。
- 提示调控ER伴侣蛋白或葡萄糖代谢可能影响FVIII分泌效率。
局限性
- 研究为体外/细胞水平机制探索,未报告临床样本或体内数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Hemophilia A, an X-linked bleeding disorder caused by deficiency of factor VIII (FVIII), is treated by protein replacement. Unfortunately, this regimen is costly due to the expense of producing recombinant FVIII as a consequence of its low-level secretion from mammalian host cells. FVIII expression activates the endoplasmic reticulum (ER) stress response, causes oxidative stress, and induces apoptosis. Importantly, little is known about the factors that cause protein misfolding and aggregation in metazoans. Here, we identified intrinsic and extrinsic factors that cause FVIII to form aggregates. We show that FVIII forms amyloid-like fibrils within the ER lumen upon increased FVIII synthesis or inhibition of glucose metabolism. Significantly, FVIII amyloids can be dissolved upon restoration of glucose metabolism to produce functional secreted FVIII. Two ER chaperone families and their cochaperones, immunoglobulin binding protein (BiP) and calnexin/calreticulin, promote FVIII solubility in the ER, where the former is also required for disaggregation. A short aggregation motif in the FVIII A1 domain (termed Aggron) is necessary and sufficient to seed β-sheet polymerization, and BiP binding to this Aggron prevents amyloidogenesis. Our findings provide novel insight into mechanisms that limit FVIII secretion and ER protein aggregation in general and have implication for ongoing hemophilia A gene-therapy clinical trials.
引用
- Poothong J, Pottekat A, Siirin M, et al. Factor VIII exhibits chaperone-dependent and glucose-regulated reversible amyloid formation in the endoplasmic reticulum. Blood. 2020. PMID: 32128578. doi:10.1182/blood.2019002867
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。